๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Synthesis of (S)-leucine-13C3 and its metabolites

โœ Scribed by Sun-Shine Yuan; Joseph Foos

Publisher
John Wiley and Sons
Year
1981
Tongue
French
Weight
268 KB
Volume
18
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Synthesis of (2S,4S)-[5-13C] leucine, (2
Synthesis of (2S,4S)-[5-13C] leucine, (2R,4S)-[5-13C] leucine, and (2RS)-[1,2-13C2] leucine
โœ D. John Aberhart; Bruce H. Weiller ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 256 KB ๐Ÿ‘ 1 views

SYNTHESIS OF (2s , 4S)-[5-l 3C] LEUC INE , (2R ,4S)-[5-' 3C] LEUC I NE , AND (2RS)-[1 ,2-13C,] LEUCINE D. John Aberhart\* and Bruce H. W e i l l e r The Worcester Foundation f o r Experimental B i o l o g y Shrewsbury, Massachusetts 01545 SUMMARY (2RSY3S)-[4-13 ClVal i n e was d i a z o t i z e d an

Synthesis of 2H- and 13C-labelled suniti
Synthesis of 2H- and 13C-labelled sunitinib and its primary metabolite
โœ Paul W. Elsinghorst; Michael Gรผtschow ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 210 KB

## Abstract Sunitinib (Sutent^ยฎ^, Pfizer) was approved in 2006 for the treatment of gastrointestinal and renal cancer. Isotopeโ€labelled derivatives have already been prepared for PET and ADME radiography. The preparation of ^13^Cโ€ and ^2^Hโ€labelled internal standards of sunitinib (SU11248) and its

Synthesis of JTT-501 and its metabolite
Synthesis of JTT-501 and its metabolite JTP-20604 labelled with 13C
โœ A. Pignatti; D. Giribone; C. Felicini; E. Fontana ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 115 KB

## Abstract JTTโ€501 specifically labelled with ^13^C was obtained __via__ a fourโ€step synthesis at an isotopic enrichment level of 99% and in 14% overall chemical yield starting from 4โ€hydroxyโ€[ringโ€Uโ€^13^C~6~]benzaldehyde **(3)**. The hydrogenation of [^13^C~6~]JTTโ€501 over Pd/C gave [^13^C~6~]JTP

A convenient synthesis of 13C4-Leflunomi
A convenient synthesis of 13C4-Leflunomide and its primary metabolite 13C4-A77 1726
โœ Robert J. Faragher; John. M. Motto; Maciej A. Kaminski; Adrian L. Schwan ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 113 KB

## Abstract A convenient synthesis of leflunomide and its primary pharmacologically active metabolite A77 1726, each labeled with four ^13^C atoms has been achieved. Starting from ^13^C~4~โ€ethyl acetoacetate, each step of the synthesis proceeds in 60โ€“82% yield. Analysis of the mass spectra of the l